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Pregabalin has emerged as a novel drug for neuro-
pathic pain treatment. Few studies or case reports have 
demonstrated neurological side effects of its use1. The aim 
of this article was to describe cognitive disturbances in-
duced by Pregabalin in a patient diagnosed with neuro-
pathic pain due to lumbar herniated disc and radicular 
compression.
CASE REPORT
A 44-year-old woman presented to Albert Einstein 
Hospital with lumbar pain, irradiated to the posterior low-
er left limb. Neurological examination showed Lasègue’s 
sign in the left leg. Lumbar brain magnetic resonance im-
aging (MRI) disclosed degeneration and bulging herni-
ated disc with left extrusion component, compressing S1 
root in the lateral recess. Patient refused surgery, therefore 
clinical treatment for neuropathic pain was started with 
anti-inflammatory (diclofenac 50 mg, 3 times daily) and 
muscle relaxants (ciclobenzaprine 10 mg, twice daily), as-
sociated with pregabalin 150 mg, and no side effects were 
observed. After seven days, the patient still complained of 
pain. Pregabalin was increased to 300 mg daily. In the third 
day, she developed structured visual hallucinations and 
psychosis, irritability, and acute confusional state (tem-
poral and spatial disorientation). General blood exams ex-
cluded infection or metabolic abnormalities and the brain 
MRI was normal. Electroencephalogram showed temporal 
slow-waves abnormalities and delta waves in frontal re-
gions. No epileptiform discharges were found. We discon-
tinued Pregabalin, and the patient improved mental state 
after 24 hours. The free informed consent was got from the 
patient for this publication.
DISCUSSION
Pregabalin is a gamma-aminobutyric acid analogue in the 
treatment of neuropathic pain, partial-onset-seizures, fibro-
myalgia, and anxiety disorders1. Although this is originally an 
antiepileptic drug, Pregabalin seems to be an effective thera-
py for the neuropathic pain, and it has been widely used, but 
few reports have highlighted its neurological side effects. 
Recently, Zaccara et al. performed a systematic review 
and a meta-analysis in a randomized controlled trial, describ-
ing the main side effects of Pregabalin use2. The main neu-
rological side effects reported were dizziness, vertigo, inco-
ordination, balance disorder, ataxia, diplopia, blurred vision, 
amblyopia, tremor, somnolence, confusional state, attention 
disturbances, abnormal thinking, euphoria, asthenia, and fa-
tigue2. Side effects were more frequent with increasing doses2.
In general, the emergence of acute confusional state or 
delirium in healthy young people leads to extensive diagnostic 
investigation for potentially serious illnesses, such as encephalitis, 
metabolic disorders and infections, however the side effects of 
drugs should also be considered. Only few reports have described 
acute confusion state during Pregabalin use3. Also, psychosis has 
already been described in one patient, but this is a rare condition4. 
The efficacy and safety of Pregabalin in the treatment of neu-
ropathic pain have been documented in several recent data5. 
Hence, neurologists have prescribed Pregabalin more often in 
daily medical practice. We must be aware of the side effects re-
ported in this article, such as delirium, psychosis and visual hal-
lucinations, since its use has increased greatly in recent years.
In summary, the present report reinforces the idea that 
acute confusional state, psychosis, and visual hallucinations 
should be considered in the clinical spectrum of side effects 
due to Pregabalin use, especially in higher doses, and that the 
withdrawal of the medication usually improves symptoms.
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Hyperthermia is a well-known precipitant of seizures, es-
pecially in susceptible individuals and in children1,2. Its oc-
currence following epileptic seizures or exclusively peri-ictal-
ly is rarely described2.
CASE REPORT
An 80-year-old hypertensive man, with epileptic seizures of 
unknown etiology, since his 70th’s, was observed for 3 times in 
4 years with self-limited right focal motor seizures with impair-
ment of consciousness. In all these episodes, he had post-ictal 
global aphasia, right homonymous hemianopsia, right hemipa-
resis and hyperthermia (38–39.6°C). Complete clinical workups 
during these events (including C reactive protein, sedimentation 
rate, leukocyte count, thorax radiograph, urinalysis, and lumber 
puncture) ruled out an infection. Brain magnetic resonance im-
aging and computerized tomography showed old lacunar basal 
ganglia infarcts and generalized atrophy. Electroencephalogram 
(EEG) obtained in two of these episodes revealed in one of them 
slow background activity of 6–7 Hz, with continuous slow theta/
delta activity in left fronto-temporal region, with paroxysmal ac-
tivity (spikes and sharp waves) in the same localization. The pa-
tient was treated with valproate and antipyretics (paracetamol 
and lysine acetylsalicylate). The hyperthermia did not respond 
to these drugs, but resolved spontaneously in 12–18 hours and 
the neurological deficits recovered within 24 hours.
DISCUSSION
Transient post-ictal hyperthermia may follow generalized 
convulsive status epilepticus2,3. In our case, over four years of 
follow-up, the patient presented three episodes of right focal 
motor seizures with consciousness impairment and a pro-
longed post-critic with aphasia, right homonymous hemi-
anopsia, right hemiparesis, and hyperthermia. There was no 
fever preceding seizures or convulsive status epilepticus. In all 
of them, an infectious cause of hyperthermia was exhaustively 
investigated. Such research was always negative. Therefore, we 
interpreted hyperthermia as a post-ictal manifestation.
Post-ictal hyperthermia seems to be a quite infrequent symp-
tom and it has been rarely described2. Rossetti et al.2 reported two 
cases and reviewed the literature of the last 40 years. They found 
another eight reports of peri-ictal fever, which were mainly relat-
ed to non-convulsive seizures, involving all age groups (5–83 years 
old), display a relatively short duration (8–96 hours) and showed 
mostly bi-temporal EEG alterations.
The exact mechanisms that underlie the onset of hyperther-
mia in the peri-ictal period are not well established. It seems 
possible that the thermoregulatory center in the hypothalam-
ic pre-optic area may be affected by spreading epileptic activity, 
and thus cause elevated body temperature3-5. The mesial tem-
poral lobe structures have extensive connections with the neu-
roendocrine hypothalamus portion, and a discharging temporal 
focus can possibly alter hypothalamic function3. Another mech-
anism may involve vagal nerve nuclei (nucleus tractus solitari-
us) modulation during seizures2. Seizure-induced production of 
pyrogens in several brain regions, such as neocortex, amygdala, 
and hippocampus, appears as an alternative2.
The knowledge of the existence of post-ictal hyperther-
mia could improve the medical management of subjects pre-
senting with. Indeed, fever does not always imply infection, 
inflammation or malignancy, even though they are still the 
most common causes4. Whilst a seizure occurring in a febrile 
context should generally prompt investigations to detect 
an infectious etiology, repetitive occurrence of this feature 
should raise the suspicion of a post-ictal symptom.
